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Abstract
STC-l is expressed in kidney collecting duct cells and targeted to most other
nephron segments. However, its function and regulation are both unclear. The present
study explored the regulation of Stc-1 mRNA levels in vivo in rat models of dehydration
and overhydration. Dehydration caused an upregulation in Stc-1 mRNA levels in kidney
cortex and to a lesser extent the inner medulla. Antidiuretic hormone was identified as a
potential mediator of gene induction during dehydration acting through the V2 receptor.
In contrast overhydration did not produce changes in renal gene activity. Histological
studies revealed no difference in STC-1 receptor distribution along the nephron indicative
of similar targeting pathways irrespective of hydration states. Together the findings are
suggestive of a novel role for renal STC-1 in the regulation of extracellular fluid volume,
in particular during water deprivation.

K e y w o r d s : Antidiuretic hormone, dehydration, extracellular fluid, hyperosmolality,
mRNA expression, rat, real-time polymerase chain reaction, stanniocalcin-1
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1 Introduction
1.1 Stanniocalcin overview
1.1.1 Stanniocalcin in fish
Stanniocalcin (STC) is a polypeptide hormone that was first discovered in bony
fish. In fish, it is produced by specific glands called the Corpuscles of Stannius (CS) and
is secreted in classical endocrine fashion. The main function of STC in fish is the
regulation of calcium homeostasis. The gills, kidney and intestine are the target organs of
blood-borne STC. The main effect of STC signalling on the gills is a reduction in calcium
influx (Fenwick. 1974). In the kidney, STC increases phosphate reabsorption whereas in
the intestine it decreases calcium uptake (Sundell et al. 1992; Lu et al. 1994).

1.1.2 Discovery of mammalian STC and its genetic structure
More recently, STC was discovered in mammals. The first report of mammalian
STC showed that protein extracts from human kidney tissue, when injected into fish, had
effects on gill calcium transport as fish STC. Furthermore, human kidney extracts were
immunoreactive to antisera raised against salmon STC and Western blot analysis revealed
a protein of similar size to fish STC (Wagner et al. 1995). These findings stimulated
further research on mammalian STC in order to further characterize the protein and its
functions. Two types of STC genes were subsequently found in mammals and are now
referred to as STC-1 and STC-2. Mammalian STCs have 58% identity in amino acid
sequence to one another (DiMattia et al. 1998)). However, they are located on different
chromosomes and their tissue distribution and presumptive functions are different (Chang
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and Reddel. 1998; Ishibashi et al. 1998; Moore et al. 1999). The present project focuses
on STC-1.
The genomic structure of mammalian STC-1 was first described in humans (Olsen
et al. 1996). The human STC-1 gene is located on chromosome 8pll.2-p21 and consists
of 4 exons. Exons 1-3 consist of 402, 143 and 212 base pairs respectively and exon 4
contains at least 3125 base pairs. There are two untranslated regions (UTR) with the 5’
untranslated region located on exon 1 and the 3’ untranslated region representing most of
exon 4. Three CAG repeats are found in the 5’ UTR and 1 additional set of six CAG
repeats are within the 3’ UTR. Interestingly, CAG repeats have been associated with
genetic diseases such as Huntington’s disease (Chang et al. 1998). However, the
significance of the CAG repeats in STC-1 is unknown. STC-1 has also been studied in the
other mammals and high similarities in gene sequences have been observed. For example,
it has been shown that the mouse and human STC-1 transcripts have 85% nucleotide
sequence identity in the protein coding regions (Varghese et al. 1998).
Human STC-1 encodes a protein of 247 amino acid residues (human sub
structure), shares 73% amino acid identity with salmon STC and has been shown to be
biologically active when injected into fish. Similar to fish, human STC-1 is a 50 kDa
glycosylated protein. Its eleven cysteine residues allow for the formation of 10 disulfide
linkages, with the 11th unpaired cysteine enabling STC-1 to form a disulfide-linked
homodimer. It has been suggested that the biological activity of STC-1 is associated with
the N-terminus of the hormone since this region shows the highest sequence similarity
among species (Olsen et al. 1996).

COOH

3

rih

Caibohydiate moiety
Piotein coie
Disulfide linkage

Figure 1. A schematic diagram of STC-1. STC-1 is a 50 kDa homodimer of two
identical 25kDa monomers of 247 amino acids.
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1.1.3 Stc-1 gene expression in mammals
Unlike fish, where there is a specific endocrine gland contributing to STC-1
secretion, mammals lack such a gland and STC-1 expression is widely distributed among
different organs. Stc-1 mRNA expression levels are found to be the highest in the thyroid
gland, prostate and most notably the ovary. Also, Stc-1 mRNA is present in kidney,
heart, lungs, placenta, certain brain areas and in bone cells (Varghese et al. 1998; Yoshiko
et al. 1999; Worthington et al. 1999; Zhang et al. 1998). Interestingly, there are some
tissues where the Stc-1 gene is not expressed, and yet, STC-1 protein is present in
abundance. For example, in the ovary, in situ hybridization shows that Stc-1 mRNA is
found only in the theca cells. On the other hand, immunocytochemistry reveals STC-1
protein in oocytes and granulosa cells, which do not express the gene in addition to theca
cells (Paciga et al. 2003). This phenomenon occurs in a number of organs where Stc-1
gene expression is localized to one cell type while the protein is also present in nearby
cells which do not express the gene. These findings have led to the hypothesis that STC-1
is actually sequestered by its target cells. This sequestration, together with the wide
distribution of Stc-1 gene expression among different organs, suggests that STC-1 signals
locally in a paracrine fashion.

1.1.4 Role of STC-1 in the kidney
1.1.4.1 Stc-1 gene expression, protein and receptor distribution in the kidney
In situ hybridization was used to localize Stc-1 mRNA in the rat and mouse
kidney. Staining for Stc-1 mRNA appeared to be confined to the cortical and medullary
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collecting duct cells and was not found in any other tubules (Haddad et al. 1996a; Wong
et al. 1998). In contrast, in situ ligand binding studies which were used to localize STC-1
receptors reveal specific ligand binding sites in the cells of thick ascending limb (TAL),
collecting ducts (CD) and the distal convoluted tubules (DCT). Some binding was also
present on the proximal convoluted tubules (PCT) (McCudden et al. 2002).
Immunocytochemical localization of the ligand revealed the presence of STC-1 protein in
cortical TAL, DCT and cortical and medullary CD cells. However, unlike the TAL and
DCT where immunoreactivity was noted in all cells, the ligand in the CD was localized to
principal cells and alpha-type cells only. Beta-type CD cells were negative for STC-1
immunoreactivity. Additionally, STC-1 immunoreactivity has been identified in the
proximal straight tubule (Haddad et al. 1996a).
The above studies revealed that STC-1 receptors and protein were present in
different cells than Stc-1 mRNA and identified yet another organ where STC-1 was
undergoing sequestration within target cells. On this basis, it has been suggested that
STC-1 is produced in CD cells for targeting of and sequestering by cells in other tubule
types such as TAL and DCT. Moreover, the CDs which produce STC-1 are also targeted
by CD cell-derived STC-1 as they too contain STC-1 receptors.
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Rat Kidney
Normal Rat Nephron
C o rte x

O u te r Medulla

In n e r Medulla
‘ S tc -1 m RNA
S TC 1 protein
IS T C -1 receptors
Tarqetinq pathways

Figure 2. Representative diagram of rat kidney (left) and normal rat nephron
(right). In the normal rat nephron, STC-1 receptors ( • ) and protein ( O ) are localized
throughout the TAL, DCT and CD. In contrast, Stc-1 mRNA ( O) is confined to the
cortical and medullary CD. Two alleged CD derived STC-1 targeting pathways are
indicated by arrows. CD derived STC-1 is thought to target both the TAL and back upon
the CD cells (TAL, thick ascending limb; DCT, distal convoluted tubule; CD, collecting
duct).
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1.1.4.2 Intracellular localization of STC-1 protein and receptor in kidney
Subsequent to the histological identification of STC-1 receptor binding sites on
nephron cells, the pattern of receptor distribution at the subcellular level was also
assessed. As stated above, STC-1 receptor binding activity was detected throughout the
CD system. However, the pattern of binding when viewed histologically, was different in
cortex and medulla. Cortical CD cells had more intense binding, which was punctate in
appearance (McCudden et al. 2002). This punctate distribution of receptors suggested that
they might be confined to specific subcellular structures. Receptor binding on kidney
subcellular fractions showed that binding activity was concentrated on both the plasma
and mitochondrial membranes (McCudden et al. 2002). Further analysis using
electromicroscopy and immunoassays found that the ligand was concentrated within the
mitochondrial matrix (McCudden et al. 2002). Furthermore, the majority of ligand and
receptor binding sites were located on or within the mitoplast and its associated
membrane (McCudden et al. 2002). This indicated that STC-1 targeting to nephron cells
was destined for the inner mitochondrial matrix.
1.1.4.3 STC-1 function in kidney
Despite the kidney being the site of STC-1 discovery in mammals, very little is
known about STC-1 function in this organ. Therefore, a primary focus of STC research
remains the kidney and the available data is constantly changing. Of the few in vivo
experiments performed on mammalian kidney, it has been shown that STC-1 causes a
reduction in renal phosphate excretion due to an increase in sodium-phosphate (Na+/Pi)
cotransporter activity which is located within the proximal tubule brush-border
membrane. However, the decrease in phosphate excretion did not change plasma levels of
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phosphate or calcium (Wagner et al. 1997). Therefore, the reduction of phosphate
excretion is thought to have a purely local significance at the level of nephron cell.
As mentioned earlier, both STC-1 and its receptor are located on and within the
mitochondrial matrix. To address the physiologic importance of mitochondrial STC-1,
functional studies were performed on isolated mitochondria and cells. The mouse IMCD3 cell line (inner medullary collecting duct) was chosen for whole cell experiments
because it has STC-1 receptors but does not produce large amounts of STC-1 and is
therefore, not targeted by significant amounts of endogenous hormone.
The assessment of mitochondrial function was done using a Clark-type electrode
for measuring oxygen consumption rates in isolated mitochondria and cells. In both
instances, STC-1 had stimulatory effects on oxygen consumption in a time- and dosedependent manner (Ellard et al. 2007). The effect on oxygen consumption by cells
increased with the length of treatment time, to a maximum of 52% after 24 hours and was
concentration-dependent between 5-500 nM of the hormone. Interestingly, the increases
in oxygen consumption did not result in corresponding increases in ATP production
(Ellard et al. 2007). This indicated that while STC-1 increased respiration rate, at the
same time it uncoupled oxidative phosphorylation.
The exact mechanism of respiratory uncoupling is not well understood. One report
has shown that STC-1 upregulates uncoupling protein-2 (UCP-2) levels in cultured
macrophages (Wang et al. 2009a). Whether or not this effect is specific to macrophages
or applicable to kidney cells as well remains to be established. It is possible that renal
STC-1 also acts through UCP-2, which is highly expressed within the kidney (Fleury and
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Sanchis. 1999). If this is true, STC-1 may upregulate UCP-2 in the kidney to increase the
permeability of the inner mitochondrial membrane, thereby allowing reentry of protons to
the inner matrix and in this way, reduce the electrochemical proton gradient necessary for
ADP phosphorylation.
1.1.4.4 Regulation of Stc-1 gene expression and secretion by the kidney
Some studies on renal STC-1 gene regulation have been conducted and can
possibly serve as a link towards an understanding of STC-1 function within the kidney.
The first of these studies characterized the regulation of STC-1 gene expression in
the rat kidney by dietary calcium and phosphate. It showed that STC-1 mRNA was
downregulated in adult rats maintained on a high calcium diet, an effect that was unique
to the medulla (Deol et al. 2001). A low phosphate diet decreased mRNA expression
whereas a high phosphate diet increased STC-1 mRNA levels. However, these changes
took place in the cortex and the outer medulla while transcript levels in the inner medulla
were unaffected. Since a low phosphate diet leads to transient hypercalcemia, and vice
versa, the reduction of STC-1 gene expression by high calcium diet and high phosphate
diet in the opposite directions was expected. Why the STC-1 gene is differentially
regulated throughout the kidney is not clear. However, findings are indicative of there
being different regulatory mechanisms in cortex and medulla (Deol et al. 2001).
STC-1 gene expression is also upregulated by calcitriol, the active form of vitamin
D3 which increases calcium reabsorption in the kidney (Honda et al. 1999). Together, the
two studies thus sited link renal STC-1 to calcium regulation. However, as STC-1 does

10

not affect plasma electrolyte levels of calcium or phosphate it is likely involved in the
regulation of intracellular levels of calcium and phosphate as opposed to systemic levels.
In addition, it has been noted that renal Stc-1 mRNA levels in the mouse change
during postnatal development. Stc-1 mRNA levels were found to be the highest on the
first day of life and then gradually decreased until the 28th day. Interestingly, aquaporin-2
(a water channel on the apical membrane of CD principal cells) increased over this period
of time, indicating a possible correlation between STC-1 and aquaporin-2 expression
levels (Deol et al. 2001). It is well established that neonates are incapable of efficient
renal water regulation due to the lack of aquaporin-2. Therefore, it is possible that STC-1
plays a role in renal water conservation. This hypothesis was explored further on the
kidney cell lines as well as in dehydrated rats, a model in which water conservation is
maximized.
1.1.4.5 Regulation of Stc-1 gene expression and secretion in the kidney cells
Several in vitro studies have shed light on our present knowledge of Stc-1 gene
regulation. In experiments using MDCK-II cells (Madin-Darby canine kidney cells- a
kidney collecting duct cell line capable of STC-1 production), it was shown that after
incubation in high osmolality media (produced by added NaCl), Stc-1 gene expression
and protein secretion were both upregulated in a time- and tonicity-dependent manner
(Sazonova et al. 2008b; Sheikh-Hamad et al. 2000). Interestingly, the presence of
physiological levels of extracellular calcium was necessary for the upregulation of Stc-1
gene expression (Sheikh-Hamad et al. 2000). Furthermore, the addition of organic
osmolytes (betaine and inositol) to the media attenuated the Stc-1 gene upregulation
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occurring in the presence of high osmolality (Sheikh-Hamad et al. 2000; SheikhHamad,D. et al. 1994; Sheikh-Hamad,D. et al. 1996; Sheikh-Hamad et al. 1997).
Besides high osmolality, high calcium concentrations have also been shown to
affect Stc-1 mRNA levels in MDCK-II cells. Increasing concentrations of calcium
chloride in the media (2-10pM) downregulated Stc-1 gene expression (Sazonova et al.
2008a).

Also, the effects of several hormones such as angiotensin-2 (ANG2), atrial

natriuretic factor (ANF) and antidiuretic hormone (ADH) on STC-1 gene expression were
tested in this cell line although none of the hormones significantly affected STC-1
secretion (Terada et al. 1994).
Few details are available regarding the cellular mechanisms by which
hyperosmolality upregulates the Stc-1 gene. One report has shown that hyperosmolality
activates protein kinase C (PKC), phospholipase C (PLC) and inositol 1,4,5-trisphosphate
(IP3) in the MDCK cell line (Terada et al. 1994) yet it remains to be determined whether
STC-1 is affected by this pathway.
In light of the finding that increases in extracellular calcium concentration
decreased STC-1 secretion, STC-1 receptor regulation was also tested in the MDCK-II
cell line. The results revealed a progressive increase in STC-1 receptor levels in response
to high calcium levels. On the contrary, there were no changes in receptor levels in
response to the stimulation of STC-1 secreted by NaCl (or by hypertonicity) in the same
cell line (Sazonova et al. 2008a). Therefore, the receptor appears to be upregulated in
response to low ligand levels but unaffected by ligand excess.
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1.1.5 Role of STC-1 in the muscle-skeletal system
Studies on cultured fetal rat calvaria cells have shown that human recombinant
STC-1

treatment

increases

osteogenic

development,

while

STC-1

antisense

oligonucleotides have the opposite effect (Yoshiko et al. 2003). STC-l’s involvement in
osteogenesis was also indicated by studies conducted in mice overexpressing STC-1. Two
transgenic mouse models have been developed. In the first model transgene expression
was under control of the metallothionein promoter (MT-hSTCl) so gene expression was
nearly ubiquitous. In the second model, the transgene was under the control of the myosin
light chain promoter (MLC-hSTCl) such that the gene expression was confined to
skeletal myocytes (Varghese et al. 2002; Filvaroff et al. 2002).
Both overexpressing lines exhibited growth retardation. In MLC-hSTCl mice,
skeletal changes were described which included shortening of bone length and narrowing
of the growth plate, which is an important indicator of bone age. High levels of STC-1
were present in the chondrocytes moving from the proliferative to the hypertrophic zone,
suggesting its involvement in chondrocytes maturation and growth plate closure.
Additionally, decreases in trabecular bone thickness and density were observed with no
change in trabecular number or mineralization. Also, morphological changes in skull
thickness were present and revealed decreased osteoclast activity but no changes in
osteoblast marker expression (Filvaroff et al. 2002). Skeletal muscles in MLC-hSTCl
mice weighed less than those of age matched controls and had enlarged mitochondria.
Functionally, the muscle twitch response was significantly weaker in MLC-hSTCl mice
than in weight matched, younger controls (Filvaroff et al. 2002).
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MT-hSTCl mice had increased serum phosphate levels which was not the case for
the MLC-hSTCl mice in which transgene expression was confined to myocytes. This
finding was interesting because earlier studies in wild type rats had shown that acute
injections of STC-1 decreased renal phosphate excretion, however, without changing
plasma levels of phosphate (Varghese et al. 2002). The difference may be indicative of
there being differential effects of low versus high serum levels of the hormone.
It is important to note that while studies on transgenic mice have contributed a
great deal to the understanding of STC-1 function, there were some limitations in these
models. First, STC-1 was present in high concentrations in the serum of transgenic mice
(Filvaroff et al. 2002) when normally, it is undetectable in the serum of wild type animals
(aside from during pregnancy and lactation)(Paciga et al. 2002). Secondly, there was a
lack of data showing that Stc-1 gene expression among organs had a similar pattern in
transgenic and wild type mice. Therefore, it is possible that tissues most heavily targeted
by STC-1 in transgenic mice were unaffected in the normal phenotype and vice versa.

1.1.6 Role of STC-1 in neurons and heart
Stc-1 mRNA and protein are present in fully differentiated neurons in both human
and mice (Zhang et al. 1998). Stc-1 is also expressed in pyramidal cells of the cortex and
hippocampus as well as in Purkinje cells of the cerebellum, all of which are highly
sensitive to ischemia (Chang et al. 2003).
At present, it is thought that STC-1 has cytoprotective properties in all neuron
cells. For example, Paju cells (cell line derived from human neural crest) transfected with
Stc-1 cDNA display higher survival rates when exposed to hypoxic stress and lower
intracellular calcium levels than non-transfected control. Additionally, treatment of Paju
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cells with STC-1 increased the uptake of inorganic phosphate, another finding resembling
its actions in the kidney. Consequently, it can be concluded that STC-1 may induce its
cytoprotective effects through the lowering of intracellular calcium concentration
indirectly via an increase in phosphate uptake (Zhang et al. 2000).
In vivo experiments also explored STC-l’s cytoprotective properties. STC-1
expression levels increased after exposure of brain tissue to hypoxic preconditioning
(induced chronic hypoxia which increases resistance of involved tissues to acute ischemic
damage). This upregulation was found to be mediated by interleukin-6 (IL-6) which is a
prosurvival protein involved in cell proliferation, differentiation and apoptosis.
Experiments on both cell lines and IL-6 knockout mice confirmed that the STC-1
upregulation was mediated by IL-6. Therefore, it is likely that STC-1 was induced in
ischemic brain tissue for cytoprotection (Westberg et al. 2007b). Similar to brain tissue,
STC-1 was shown to be upregulated in cardiomyocytes after hypoxic preconditioning.
This effect was also found to be mediated through IL-6 protein (Westberg et al. 2007a).
Interestingly, STC-1 is present in fully differentiated neurons but not in immature
ones (Zhang et al. 1998). Moreover, other reports have revealed that STC-1 is involved in
the neuron cell differentiation (Wong et al. 2002). It has also been shown that less
differentiated Paju cells are more susceptible to toxins (Teplova et al. 2004). Therefore, it
is possible that the neuroprotective properties of STC-1 are somehow associated with cell
differentiation.
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1.1.7 Role of STC-1 in ovaries and mammary gland
Mammalian Stc-1 gene expression is highest in the ovaries likely reflecting a
unique action in these organs. Most Stc-1 mRNA is confined to the thecal-interstitial
cells, whereas STC-1 protein is more widely distributed, being found in oocytes and
corpus luteal cells in addition to theca cells (Varghese et al. 1998). Such distributions of
Stc-1 mRNA and protein demonstrates once more ligand sequestration and paracrine
action of the hormone, which as previously mentioned, has also been described in the
other organs such as kidney and liver (Haddad et al. 1996a; Wong et al. 1998; McCudden
et al. 2002).
Interestingly, during pregnancy and lactation STC-1 becomes detectable in the
serum, indicating that in addition to paracrine signalling, STC-1 has a classical endocrine
function during these physiological states. It is likely that serum bom STC-1 is produced
by the ovaries for targeting of other organs, since STC-1 concentrations in the serum are
highly correlated with Stc-1 mRNA levels in the ovaries (Deol et al. 2000).
Stc-1 mRNA levels were found to be increased in the ovaries during pregnancy
and lactation (Deol et al. 2000). In the mouse, ovarian STC-1 secretion was shown to be
upregulated by human chorionic gonadotropin (hCG). Human chorionic gonadotropin is
capable of binding luteinizing hormone receptors normally targeted by luteinizing
hormone during pregnancy. The PKA pathway is also involved in hCG-mediated STC-1
signalling. (Paciga et al. 2002) Stc-1 gene upregulation is also observed in the uterus and
embryo during implantation and the early stages of pregnancy, indicating a possible role
in gestation (Stasko et al. 2001). Functional studies have also shown that STC-1 can
downregulate the secretion of progesterone by luteal cells in culture (Paciga et al. 2003).
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The mechanism entails STC-1 targeting to the cholesterol lipid droplets which possess
STC-1 receptors. It has been suggested that in doing so, STC-1 reduces the availability of
cholesterol which is essential for steroidogenesis. Therefore, in the intact ovary, theca
cell-derived STC-1 may function to regulate progesterone production by nearby luteal
cells.
The mammary gland is another organ that has been shown to be affected by STC1 during pregnancy and lactation. STC-1 receptor distribution is of great interest in the
mammary gland because of the unique regulatory changes that occur. In the non-pregnant
state, STC-1 receptors are primarily localized to the mitochondria, like in other organs
(Haddad et al. 1996b). However, during pregnancy and lactation, these mitochondrial
receptors are downregulated and supplanted by marked receptor upregulation in the
nuclei of milk-producing alveolar cells. Such a shift in receptor localization has only been
demonstrated exclusively in the mammary gland (Hasilo et al. 2005). The role of
mammary gland-targeted STC-1 in lactation has also been demonstrated in vivo in
lactating mice. Animals injected with STC-1 antiserum had no changes in milk output,
but the milk contained 40% less triglyceride content. As a consequence, the pups from
mice with suppressed STC-1 targeting experienced growth retardation due to the
significant reduction in milk caloric value (Zaidi et al. 2006).

1.1.8 STC-1 and cancer
Numerous studies have implicated STC-1 in carcinogenesis in the sense that high
levels of Stc-1 gene expression have been observed in malignant tumours. Examples of
cancers where change in Stc-1 expression have been observed as compared to the normal
surrounding tissue include breast adenocarcinoma, ovary, colon, hepatocellular
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carcinomas, and MEN2B medullary thyroid carcinomas (Kahn et al. 2000; Welcsh et al.
2002; Gerritsen et al. 2002; Okabe et al. 2001; Fujiwara et al. 2000; Watanabe et al. 2002;
Ismail et al. 2000; McCudden et al. 2004). Based on the above, and also the finding that
Stc-1 mRNA has been detected in the blood of cancer patients (Fujiwara et al. 2000), it
has been proposed that STC-1 could have value as a molecular marker of carcinogenesis.
(Fujiwara et al. 2000).
Interestingly, while STC-1 was upregulated in most types of cancer, one study has
found it to be decreased in hormone responsive breast and ovarian cancer cell lines
(Welcsh et al. 2002). Moreover, expression of STC-1 is strongly correlated with BRCA1
expression (Welcsh et al. 2002) which is a protein known to repress estrogen induced
genes associated with the tumourgenesis (Miki et al. 1994; Thompson et al. 1995).
Therefore, it is possible that STC-1 plays some protective role in the estrogen-dependent
carcinogenesis (Welcsh et al. 2002).

1.2 Kidney function during dehydration
Alterations in water or electrolyte balance are major sources of stress to an
organism. One of the physiologic situations leading to water and electrolyte imbalance is
dehydration, a condition that results from greater water loss than water intake.
The major challenges the body faces during dehydration include extracellular fluid
volume contraction and an increase in its osmolality (Brazzuna et al. 1975). Since the
kidney is the primary organ responsible for water and electrolyte regulation most adaptive
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mechanisms directed to normalize the volume and content of the extracellular fluid
compartment involve the kidney.
In a dehydrated state, changes in kidney function result in anti-diuresis, natriuresis
and a resulting increase in urine osmolality. These changes in water reabsorption and
sodium excretion are brought about by complex signaling pathways which include
paracrine, endocrine and neuronal input.
The above perturbations pose a stress to the kidneys themselves, in particular the
medullary zone, which is required to function under hyperosmotic conditions in order to
maximally increase water reabsorption. Therefore, additional local mechanisms are
required to adapt medullary nephron segments to this unfavorable environment. The
present section summarizes the current knowledge of kidney function and the important
changes that occur during dehydration.

1.2.1 Plasma biochemistry during dehydration
Studies have shown that a prolonged period of dehydration leads to significant
increases in plasma osmolality and sodium (Na+) concentration. However, plasma
potassium (K+) levels decrease, and other solute concentrations as well as plasma pH do
not change (Brazzuna et al. 1975; Brazzuna et al. 1975). Total body Na+ and K+ decreases
during dehydration due to the resulting increases in natriuresis and kaliuresis (Bennett and
Gardiner. 1987a; Zucker et al. 1982; Merrill et al. 1986).
Antidiuretic hormone (ADH), is increased dramatically during dehydration as it
constitutes the major hormone responsible for water conservation in the kidney (Blair
West et al. 1979). It has been shown that dehydration also results in the stimulation of the
renin-angiotensin-aldosterone system, resulting in increased levels of plasma renin and

19

angiotensin II (ANGII) (Blair-West et al. 1979; Bennett and Gardiner. 1987a). In some
species such as the dog there is a dissociation occurring between ANGII and aldosterone,
such that plasma aldosterone remains unchanged during dehydration despite the high
serum levels of renin and ANGII. In the rat, however, serum aldosterone levels are
elevated during dehydration (Zucker et al. 1982; Metzler et al. 1986; Ramsay et al. 1988).

1.2.2

Glomerular apparatus during dehydration
The first kidney structure involved in the regulation of water conservation is the

glomerulus. The glomerulus is located in the cortical zone of the kidney where the
capillary walls come into contact with Bowman’s capsule membranes to form a barrier
that is permeable to electrolytes and water, but not proteins.
Filtration through the glomerular capillaries is driven by two major forces:
hydrostatic pressure and oncotic pressure. Therefore, filtration rate depends on the
difference in hydrostatic and oncotic pressures between the glomerular capillaries and
Bowman's capsule, as well as degree of membrane permeability which determines the
filtration coefficient. In general, substances affecting the glomerular filtration rate (GFR)
are numerous and mostly comprise vasoconstrictors and vasodilators which affect
arteriole resistance and/or the membrane permeability. Examples include ANGII, ADH,
dopamine and prostaglandins (Seldin and Giebisch. 1992) Numerous studies have shown
that GFR is decreased during dehydration (Prasad et al. 1988; Hope and Tyssebotn. 1983;
Selen and Persson. 1983a) likely due to a decrease in glomerular plasma flow rate and in
the glomerular capillary ultrafiltration coefficient, both of which are hormonally regulated
(Yaredetal. 1985).
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The renin-angiotensin-aldosterone system is the most powerful mechanism
controlling GFR. Renin release is triggered by dehydration and leads to the formation of
ANGII. ANGII affects both afferent and efferent arteriole resistance (Dworkin et al.
1983). During dehydration when kidney perfusion is reduced, ANGII decreases GFR by
reducing capillary hydrostatic pressure. This was demonstrated in water deprived rats
which were administrated saralasin (a competitive ANGII inhibitor) (Yared et al. 1985).
Prostaglandins 12 and E2 are also secreted during dehydration and both have been shown
to decrease GFR (Schor et al. 1981).
ADH, acting through the V ia receptor subtype, has been shown to decrease the
filtration coefficient, and GFR in the hydrated state (Dworkin et al. 1983). However,
during dehydration ADH regulates GFR in the opposite direction. One report indicated
that, in water deprived rats, administration of the ADH blocker d(CH2)ATyr(Me)AVP
resulted in a decrease in GFR. Possibly, the effect was due to stronger vasoconstrictive
action of ADH on the extrarenal vasculature in comparison to the intrarenal vessels with
the resulting increase in the intrarenal vascular flow rate (Yared et al. 1985). It has also
been shown that dopamine increases GFR during dehydration (Baylis and Brenner. 1978;
Goldberg. 1972). Such modulation in GFR by the above hormones is likely directed to
maintain a certain level of filtration necessary for effective clearance of metabolic waste
products.
Tubuloglomerular (TGF) feedback is yet another important factor regulating GFR
(Seldin and Giebisch. 1992). In general, TGF is thought to stabilize GFR and be
responsible for the adjustment of single nephron glomerular filtration rate (SNGFR) in
accordance to the flow rate in the macula densa that makes up the early distal tubule. It
has been shown that SNGFR has an oscillatory behavior and that TGF is the factor
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responsible for these oscillations. The macula densa is the sensory part of the feedback
system, where luminal sodium chloride (NaCl) concentration is monitored. Studies have
revealed that TGF is initiated by changes in NaCl transport through the furosemide
sensitive Na+-K+-2Cr cotransporter but not by changes in osmolality created by non-ionic
substances. Changes in NaCl transport trigger signaling changes in macula densa.
Although how exactly signals are passed from the macula densa to the glomerulus is not
well understood, it has been suggested that adenosine, prostaglandins, calcium ions,
cAMP and local renin-angiotensin system serve as TGF signals. The glomerulus is the
effector in the TGF pathway. Signals from the macula densa cause changes in afferent
and efferent arteriole pressure as well as filtration coefficient, all of which affect SNGFR.
In general increases in tubular Na+ cause a decrease in GFR, whereas decreases in tubular
Na+content increase GFR.
During dehydration, the TGF is activated by the rise in tubular Na+ levels and
attempts to reduce GFR. Increased TGF sensitivity was found during dehydration along
with a higher magnitude of the TGF response. Possible mechanisms influencing the
increase in TGF sensitivity during dehydration include a reduction in interstitial pressure
in macula densa and rise in plasma ANGII (Selen et al. 1983).

1.2.3 Proximal tubules during dehydration
The proximal convoluted tubules are the most important sites for the regulation of
water, electrolytes and acid balance. They participate in the reabsoption of Na+, K+, Ca ,
HC03", CP, HP042, glucose, amino acids, citrate and many other solutes, as well as the
secretion of H+, K+ and NH4+.
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As much as 70% of the filtered Na+ and water are reabsorbed by the proximal
tubule (PT) cells. Therefore, minimal disturbances in the reabsorptive process can result
in major changes in water and electrolyte homeostasis. Sodium reabsorption is regulated
by many diverse mechanisms. On the other hand, water reabsorption is passive in this
nephron segment and depends almost entirely on the sodium gradient. Water transport in
the proximal convoluted tubules takes place through aquaporin

1

channels located on the

apical and basal membranes and via paracellular transport.
Sodium transport through the PT is complex because of the number of transporters
involved. However, Na+/H+ exchangers (NHEs) and the Na+/K+-ATPase, both of which
are tightly regulated, are the largest contributors to Na+ reabsorption. For instance, NHE3
is responsible for the reabsorption of two thirds of Na+ and water while Na+/K+-ATPase is
the only transporter located on the basolateral cell membrane capable of maintaining the
transcellular Na+ gradient. Therefore, further discussion is warranted on these two
transporters (Seldin and Giebisch. 1992).

1.2.3.1 NHE regulation in the proximal tubules during dehydration
There are several known NHE isoforms (NHE1-NHE9). However, only NHE3
and NHE8 are known to be expressed in the luminal side of the PT epithelium and to be
involved in Na+ reabsorption (Biemesderfer et al. 1993; Amemiya et al. 1995). NHE3 is
highly expressed in adulthood while NHE8 is the prevalent isoform in neonates (Goyal et
al. 2003; Goyal et al. 2005; Becker et al. 2007). NHE1 may also be of some importance
during dehydration as it is responsible for nephron cell adjustments to the hyperosmolar
environment typical in the dehydrated state. NHE1 is expressed on the basolateral side of
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all nephron cells with the exception of macula densa and intercalated cells of the cortical
collecting ducts which lack NHE1 completely (Bobulescu and Moe. 2009).
NHE3 function depends on the inward Na+ gradient across the luminal face of PT
cells created the high levels of filtrate sodium (140mM) and low levels of intracellular
Na+ (5 mM) maintained by the basolateral Na+/K+-ATPase. Although ATP is not
hydrolyzed by NHE3 to power transport, it binds NHE3 and is required for optimal
transporter activity (Cabado et al. 1996; Cassel et al. 1986). Because NHE3 is regulated
by multiple factors and mechanisms, the net effect of each can be difficult to estimate.
However, they include urine acidity, hyperosmolality, ANGII and ANP, all of which are
highly relevant to dehydration (Donowitz and Li. 2007).
Low pH has been shown to increase NHE3 activity and during dehydration urine
pH rises faster along the nephron due to a decrease in filtrate flow rate combined with
spared ammonium secretion. Therefore, higher urine acidity during dehydration is likely
to increase NHE3 activity (Yang et al. 2000).
ANGII has a dose dependent action on NHE3. Physiological doses (0.01-0.1 nM
range) stimulate NHE3 while higher pharmacological doses (lOOnM) inhibit it (Harris
and Young. 1977). The mechanism of ANG II action on NHE3 is not well understood.
However, recent studies have showed that it activates cellular pathways through the ATI
G- protein coupled receptor. Subsequent effects include inhibition of adenylyl cyclase,
activation of phospholipases A2, C or D and Ca

release in response to inositol-1,4,5,-

triphosphate or calcium channel opening induced by the arachidonic acid metabolite 5,6,epoxy-eicosatrienoic acid (Harris et al. 1996). The final steps of the pathway by which
physiological doses of ANGII act are attributed to an increase in cytosolic Ca

and
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consequent enhancement of Na+/H+ exchange activity (Dominguez et al. 1987; Welsh et
al. 1988). Increases in intracellular Ca2+ concentration are due to Ca2+ entry, and not its
release from the intracellular stores (Welsh et al. 1988).
Unlike ANG II, dopamine has inhibitory effects on NHE3. Dopamine is
upregulated by the high serum Na+ levels of dehydration and promotes natriureseis to
compensate for the decrease in extracellular volume. Dopamine is produced within the PT
cells and signals in autocrine and paracrine fashion. There are two known types of
dopamine receptors: Dl-like receptors (D1 and D5) and D2-like receptors (D2, D3 and
D4). Proximal tubules have been shown to express both Dl- and D2-like receptors.
Dopamine induces its natriuretic effects mostly through Dl-like receptors which are Gprotein coupled. Several pathways can be activated by Dl-type receptors which may
contribute to the decrease in NHE3 abundance. It is necessary to stress the importance of
dopamine as a natriuretic hormone during dehydration because it regulates not only
NHE3 activity but also Na+/K+-ATPase activity, which is essential for maintaining the
Na+ gradient that facilitates Na+ reabsorption (Aperia. 2000).
The next important factor regulating NHE3 activity is hyperosmolality itself.
Serum and urine hyperosmolality, high hematocrit and high Na+ concentrations are
among the most important consequences of dehydration. Hyperosmolality has a dual
effect on NHE3 activity depending on the time-course. Acute hyperosmolality, which
occurs within a few hours of water withdrawal, has inhibitory effect on NHE3 (Nath et al.
1996). In contrast, chronic hyperosmolality extending beyond 48 hours stimulates NHE3
(Ambuhl et al. 1998). The acute inhibitory effects of hyperosmolality can be also
secondary to dopamine. Dopamine is upregulated in the kidney by high ECF Na+
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concentrations (Aperia. 2000; Alper and Moore. 1982) Since high Na+ is the primary
contributor to the hyperosmolar state during dehydration, it is likely that dopamine is a
part of the natriuresis mechanism induced by hyperosmolality. Finally, it is important to
mention ANP, an important regulator of NHE3 in PT cells. ANP indirectly affects Na+
reabsorption via its ability to stimulate dopamine release for the inhibition of NHE3
(Aperia. 2000). Generally, however, ANP is suppressed during dehydration, and
therefore, its natriuretic effects are diminished during water withdrawal (Makino et al.
1996).
As mentioned above acute and chronic forms of NHE3 regulation have been
identified. Acute regulation occurs within 24 hours, while chronic regulation takes more
than 24 hours. The mechanisms governing acute and chronic regulation are different. The
best known acute mechanisms entail NHE3 phosphorylation and trafficking leading to its
intracellular redistribution and downregulation on the luminal membrane. Control at the
level of transcription and synthesis/degradation of pre-existing protein are responsible for
the chronic regulation of NHE3 activity as its half-life is relatively long (20 hours)
(Donowitz and Li. 2007).

1.2.3.2 Na+/K+-ATPase regulation in the proximal tubules during dehydration
Na+/K+-ATPase plays a crucial role in water and electrolyte balance during
dehydration. It is the major Na+ transporter on the basolateral membrane and is present
along the entire nephron. Functionally, it creates a transcellular Na+ concentration
gradient between the lumen and the nephron cell cytoplasm and in this way facilitates Na+
reabsorption by NHE3 across the apical membrane. ATP hydrolysis is required for the
function of the transporter, and therefore energy metabolism can influence its activity
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(Feraille and Doucet. 2001). Na+/K+-ATPase is highly regulated and this regulation varies
according to nephron segment. In PT cells, the pattern of regulation resembles that of the
NHE3, as both transporters are functionally connected. The major regulators of Na/KATPase during dehydration are ANGII and dopamine. Low physiological concentrations
of ANGII stimulate the Na+/K+-ATPase and high concentrations inhibit it (Bharatula et al.
1998) though the pathway under which the latter occurs is unclear. In contrast, dopamine
always acts as an inhibitor of the Na+/K+-ATPase and is upregulated to promote
natriuresis during dehydration (Aperia. 2000).

1.2.4

Thin segment of Henle’s loop during dehydration
The thin segment of Henle’s loop is divided into descending and ascending limbs

based on epithelium morphology and function and the direction of filtrate flow. The thin
segment of Henle’s loop always begins at the junction of the outer and inner stripes of the
outer medulla but has a variable length depending on nephron subtype. It may end in the
inner stripe in the superficial nephrons or extend to the papilla in the case of
juxtamedullary nephrons. Water and Na+ transport both take place in Henle’s loop. The
descending limb is responsible for both water and Na+ recycling while the ascending limb
is only involved in Na+ recycling.
The descending limb is highly permeable to water. This nephron segment is not
regulated by hormones and water reabsorption fully depends on the osmotic gradient in
the medullary interstitium, which varies substantially depending on the location of the
loop. The lower it resides in the medulla, the higher the interstitial osmolality and
resulting osmotic gradient becomes (Seldin and Giebisch. 1992). The osmotic pressure of
the medullary interstitium increases markedly during dehydration and is followed by a
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corresponding increase in water reabsorption by this segment (Selen and Persson. 1983b).
Na+ recycling in the descending limb varies depending on epithelial cell type. For
example, long loops have higher sodium permeability than short loops, likely reflecting
their role in creating medullary osmolar gradient. Transport is passive everywhere,
however, with sodium moving out of the luminal filtrate according to its concentration
gradient. The sodium recycling rate must be higher during dehydration due to higher
sodium concentration in the interstitium and consequently, concentration gradient (Seldin
and Giebisch. 1992).
In contrast to the descending limb, the ascending thin limb has a very low
permeability to water and high permeability to sodium. Sodium reabsorption is driven by
an electrochemical gradient created in part by Cl' reabsorption. Sodium transport is
passive in this portion of the tubule and is thought not to be hormonally regulated. On the
other hand, the latest studies have shown the presence of ADH-sensitive adenylate
cyclase. Recall, that ADH is highly upregulated during dehydration. However, the action
it produces in the thin ascending limb of Henle’s loop is unknown. The role of the thin
ascending limb is related to the dissociation of Na+ and water reabsorption. This
dissociation leads to creation of the osmotic gradient for passive water reabsorption by
CD cells and the descending thin limb, a mechanism referred to as countercurrent system.
The thin ascending limb comprises the initial part of the countercurrent system (Seldin
and Giebisch. 1992).

1.2.5 Thick ascending limb of Henle’s loop during dehydration
The thick ascending limb (TAL) is the final portion of Henle’s loop and ends in
the macula densa. Therefore, ion transport in the TAL regulates the osmolality of macula
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densa filtrate and therefore plays a role in tubular glomerular feedback. Consequently,
TAL has also an influence on glomerular filtration rate.
The transport properties of TAL cells differ from those of the thin descending
limb in that they are impermeable to water and yet permeable to a number of solutes
including Na+, K+, HCO3 ', Cf, Ca2+ and Mg2+to name only some. About 15% of the total
filtered sodium is reabsorbed by TAL cells. Since the TAL is permeable to Na+ but
impermeable to water, it is commonly referred to as the diluting segment and helps drive
the countercurrent system (Seldin and Giebisch. 1992).
TAL contains Na+/K+-ATPase on the basolateral membrane, which is regulated by
numerous hormones. During dehydration, ADH, dopamine and ANGII are the most
influential hormones affecting sodium transport in the TAL. ADH acts primarily through
V2 receptors which are strongly expressed in medullary TAL and more weakly in the
cortical portion, to regulate Na+ reabsorption. The mechanism of action includes an
increase in Vmax of the Na+/K+-ATPase and increase in transporter abundance on the
basolateral membrane, resulting in an upregulation of sodium transport across the
basolateral membrane (Ecelbarger et al. 2001). In contrast, V ia receptors are absent from
TAL cells (Tashima et al. 2001). ADH binding to V2 receptors leads to activation of
adenylate cyclase, an increase in cAMP production and the activation of protein kinase A
(PKA) (Mutig et al. 2007).
Besides ADH, hyperosmolality further upregulates Na+/K+-ATPase gene
expression and protein production (Sakuma et al. 2005). Dopamine, ANGII and
prostaglandins are all inhibitors of TAL Na/K-ATPase activity during dehydration. Also,
Na+/K+-ATPase activity is obviously inhibited in response to ATP depletion (Chabardes
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et al. 1999; de Jesus Ferreira et al. 1998; Hussain and Lokhandwala. 1997; Yu et al.
1996).
Once Na+/K+-ATPase activity is maximally upregulated in the TAL, the activity
of apical Na+ transporters can be a crucial limiting factor for Na+ entry into the cells.
Consequently, the net increase in Na+ reabsorption that occurs in TAL during dehydration
is likely due to upregulation of transporters on the apical side of the membrane. For
example, the bumetanide-sensitive Na+-K+-2C1 cotransporter (NKCC2) and the epithelial
Na+ channel (ENaC) are directly increased by ADH (Ecelbarger et al. 2001).
Upregulation of the NKCC2 transporter is essential for Na+ reabsorption in the TAL and
is mediated by the PKA pathway (Kim et al. 1999). The regulation of K+ recycling and
basolateral Cl- removal are also necessary for the maintenance of NKCC2 activity and
they too involve PKA signaling (Hebert and Andreoli. 1984; Schlatter and Greger. 1985).
It is important to mention, however, that the PKA pathway is only efficient in the
presence of a sufficient ATP supply. Thus, in a situation where ATP becomes limiting,
PKA is overridden by the phospholipase A2 (PLA2) pathway, resulting in inhibition of
both NKCC2 and the Na+/K+-ATPase (Escalante et al. 1991).
Dopamine stimulates NKCC2, the main apical sodium transporter in the TAL
(Aoki et al. 1996). However, net Na+ reabsorption is decreased by dopamine in the TAL
due to its inhibition of Na+/K+-ATPase (Grider et al. 1998). Therefore, the inhibition of
Na+/K+-ATPase by dopamine outweighs its stimulatory effect on NKCC2.

1.2.6 Distal convoluted tubule during dehydration
The distal convoluted tubule (DCT) extends from the TAL and then gradually
transforms into the connecting tubule and finally into the collecting duct (CD).
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The cells making up the initial portion of the DCT resemble those of the TAL, in terms of
transport properties. The DCT is highly permeable to Na+ and low to water and is
hormonally regulated in a fashion similar to that of the TAL. In contrast to the initial
portion of DCT, the function of its distal portion is similar to the CD. It is highly
permeable to water and water reabsorption is regulated by ADH (Seldin and Giebisch.
1992). Because the DCT shares structural similarities with TAL and CD it likely exhibits
similar function during dehydration.

1.2.7 Collecting duct during dehydration
The collecting duct (CD) is the last segment of the nephron. Between 5-10
nephrons converge on and drain into each CD segment. The CDs commence in the upper
cortex and extend down into the inner medulla. Therefore, the osmolar environment
surrounding each CD changes considerably along its length. There is also substantial
axial heterogenisity among the cells making up CD system.
Depending on location, the CD is divided into cortical, outer medullary and inner
medullary segments. Each segment can be characterized by its specific transport
properties and function. One of the primary functions is regulated water reabsorption,
which explains the importance of this nephron segment during dehydration. Moreover, it
is the only site where water reabsorption is not directly linked to Na+ reabsorption (Seldin
and Giebisch. 1992).
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1.2.7.1 Regulation of water reabsorption in the collecting duct
Water reabsorption is a passive process in the collecting duct, driven by the
osmotic gradient created by countercurrent system described above. Additionally, Na+
reabsorption in the collecting duct itself contributes to the osmotic gradient.
As in other nephron segments, water reabsorption in the collecting duct is
exclusively transcellular. This transepithelial water transport is dependent on specific
water channels referred to as aquaporins (AQPs). Four different AQPs (AQP1-AQP4) are
responsible for water transport through nephron cells. In the kidney, AQP2, AQP3 and
AQP4 are expressed in the collecting duct while AQP1 is present in the proximal tubules
and thin descending limbs (Nielsen et al. 1993b). AQP2 is located on the apical side of
CD principal cells while AQP3 and AQP4 are found on the basolateral membrane
(Nielsen et al. 1993a; Ecelbarger et al. 1995). Basolateral AQP3 and AQP4 are much
more abundant then AQP2 on the apical membrane. Therefore, AQP2 is responsible for
the changes in water permeability of the collecting duct and consequently, regulated
water reabsorption.
ADH is the major hormone regulating water reabsorption in the collecting duct.
The expression of AQP2 on the apical membrane is tightly regulated by ADH and both
short term and long term regulation has been described. Short term regulation involves
regulated trafficking of stored AQP2 from the intracellular compartment to the apical
membrane whereas long term regulation occurs through the induction of AQP2 gene
expression. ADH signaling in the collecting duct takes place through G-protein coupled
V2 receptors located on the basolateral surface of all principal cells. Stimulation of V2
receptors leads to the activation of adenylate cyclase, increased cAMP levels and
activation of PKA. Both translocation of AQP2 vesicles and upregulation of AQP2
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transcription rely on this pathway (Cheng et al. 2009).Numerous studies have reported
that ADH is not the only factor that regulates AQP2 through V2 receptors during
dehydration (Cheng et al. 2009). Moreover, the regulation of AQP2 can also occur by
other mechanisms (Marples et al. 1998).

For example, prostaglandins secretion is

induced by ADH through V ia receptor activation, a receptor subtype associated with the
vasoconstrictive properties of ADH and expressed in the kidney vasculature and cortical
collecting duct (Tashima et al. 2001). Prostaglandins oppose the action of ADH on AQP2
during dehydration. Prostaglandins decrease cAMP levels and PKA activity and are
considered to be a part of the ADH negative feedback pathway (Seldin and Giebisch.
1992). ADH can also upregulate nitric oxide synthase (NOS) thereby, increasing nitric
oxide (NO) levels (Martin et al. 2002) which stimulates water reabsorption by the CD
(Murase et al. 2003). Its importance can be demonstrated by the fact that knockout mice
lacking NOS develop nephrogenic diabetes insipidus (Morishita et al. 2005).
Secretin and oxytocin have also both been shown to regulate AQP2 and water
reabsorption. The peptide secretin has antidiuretic properties similar to ADH. Studies
suggest that it acts through its own receptor to regulate AQP2 (Chu et al. 2007). Oxytocin
is the other hormone capable of inducing antidiuresis. Oxytocin can bind the V2 receptor,
although with a lower affinity than ADH and its antidiuretic effects is known to be
mediated primarily through V2 receptors (Terashima et al. 1999; Chou et al. 1995b; Chou
et al. 1995a).

1.2.7.2 Regulation of sodium reabsorption in the collecting duct
Changes in cell water permeability are the most important factor in the regulation
of water reabsorption at the site of the CD. However, it is important to highlight that
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changes in Na+ reabsorption in the CD takes place during dehydration as well. Changes in
Na+ reabsorption contribute to the overall osmotic gradient created by the countercurrent
system which assists in the passive reabsorption of water.
Na+ reabsorption by the CD occurs in principal cells and mediated by amiloride
sensitive epithelial sodium channels (ENaC) on the apical membrane, as well as Na+/K+ATPase on the basolateral membrane (Seldin and Giebisch. 1992). ADH binding to the
V2 receptor stimulates Na+/K+-ATPase and ENaC by the induction of PKA (Feraille et al.
2003; Feraille and Doucet. 2001) resulting in an increase in Na+ reabsorption.
Prostaglandins, dopamine and nitric oxide (NO) modulate ADH action by decreasing CD
cell Na+ reabsorption. They are all induced by ADH and constitute negative feedback
pathways (Seldin and Giebisch. 1992; Ortiz and Garvin. 2002; Martin et al. 2002).
Aldosterone is another major hormone regulating Na+ reabsorption in the CD. It is
targeted primarily to the cortical CD to increase Na+ reabsorption (Seldin and Giebisch.
1992). However, the role it plays during dehydration is not clear. Some studies conducted
on dogs have shown that its concentration is not increased in plasma during dehydration
(Zucker et al. 1982; Metzler et al. 1986; Ramsay et al. 1988). On the other hand, studies
performed on water-deprived rats do show that serum aldosterone levels are upregulated
as compared to hydrated controls (Bennett and Gardiner. 1987b; Ezzarani et al. 1985).

1.2.7.3 Inner medullary cells adaptive mechanisms to hyperosmolar environment
The osmolality in kidney tubule cells and the surrounding interstitium can vary
substantially, especially in the inner medulla. To adapt to conditions of high osmolality
such as those occurring during dehydration, CD cells employ a unique strategy.
Osmolytes capable of increasing intracellular osmolality accumulate within the cell which
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prevents cell shrinkage. These osmolytes include inositol (myo-inositol), betaine, and
sorbitol(Sone et al. 1995) and their accumulation is facilitated by the production of
specific osmolyte transporters such as the sodium/myo-inositol cotransporter (SMIT), and
the sodium/chloride/betaine cotransporter (BGT1) (Garcia-Perez et al. 1989). The
transcription of these cotransporter genes is regulated by the transcription factor, tonicity
enhanced binding protein (TonEBP) (Miyakawa et al. 1999; Cha et al. 2001). TonEBP is
distributed equally in the cytoplasm in isotonic conditions but is redistributed to the
nuclei during conditions of hyperosmolality (Dahl et al. 2001) along with an increase in
total TonEBP mRNA and protein (Woo et al. 2000).
The response of cells to the hyperosmolar state is not limited to osmolyte accumulation
and TonEBP dependent signaling. It has been shown that under conditions of high
osmolality, endothelial NOS (eNOS), inducible NOS (iNOS), neuronal NOS (nNOS)
mRNA and protein are all increased in the inner and outer medulla (Shin et al. 1999). The
function of NOS in a hyperosmolar state appears to be cytoprotective as NO is known to
reduce the damaging effects of reactive oxygen species (ROS) which some studies have
pointed out are increased by hypertonicity. (Evans and Fitzgerald. 2005a).
It has also been shown that tonicity upregulates heat shock protein-70 (HSP70)
mRNA and protein which has an antiapoptotic role in the inner medulla. Reductions in
medullary HSP70 expression induce cellular apoptosis in dehydrated rats, indicating that
HSP70 has a protective role in cells during conditions of dehydration (Neuhofer et al.
2004).
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Figure 3. Representative diagram of rat nephron during dehydration. There is a
decrease in GFR and increase in TGF; decrease in ANP signaling in the PCT, increase in
angiotensin II signaling in PCT; increase in ADH signaling, prostaglandins, NOS in the
TAL and CD; increase in AQP 2 along the entire CD; increase in HSP70 and TonEBP in
the inner medullary CD. Increase dopamine signaling takes place along PCT, TAL and
CD.
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1.3 Conclusion
As outlined in the above review, the regulation of water and sodium reabsorption
is very complex. There are multiple mechanisms which act simultaneously in each
nephron segment and can function in opposing ways to achieve a fine balance between
reabsorption and excretion of solute and water. These numerous feedback mechanisms
assure reliable functioning of the kidney but at the same time make it very difficult to
study kidney function. Alterations in one pathway or another are typically well
compensated for and do not usually result in any apparent changes in kidney function. For
example, it has been shown that rats lacking ADH are still capable of water concentration
within the CDs by alternative mechanisms. Therefore, to study a particular mechanism it
may be easier to uncover its importance (role) under conditions which pose a significant
stress on both the primary and compensatory mechanisms. Dehydration is an example of
the stress conditions because it places demands on all mechanisms responsible for
conservation of water and salts.
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1.3 Rationale for studies and hypothesis
Rationale
The rationale for this study is based upon a series of observations we and others
have made in the MDCK kidney cell line, whereby high osmolality upregulates both Stc-1
gene expression and secretion (Sazonova et al. 2008b; Sheikh-Hamad et al. 2000). As
earlier studies have revealed that STC-1 has cytoprotective properties (Zhang et al. 2000;
Westberg et al. 2007a) the increase in STC-1 levels in MDCK cells could be helpful in
cell adjustment to hyperosmolar stress. The Stc-1 gene, and its receptor are also highly
expressed in the kidney in vivo (Haddad et al. 1996a; McCudden et al. 2002). However,
few things are known about the role of STC-1 in this organ. As hyperosmolar stress is
commonly experienced by cells within the inner medulla, we wanted to determine if
hyperosmolarity also increased Stc-1 mRNA levels in vivo. Over- and under-hydration
were chosen for this study because of their marked contrasting effects on interstitial fluid
osmolality in the inner medulla.

Hypothesis
Hyperosmolarity induced by dehydration increases Stc-1 mRNA in vivo.
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2 Methods
2.1 Experimental animals and reagents
Adult male Wistar rats (250g) were obtained from Charles River Laboratories,
Montreal, QC, Canada and were and were allowed a one week acclimatization period
before being used in studies. Animals were kept on a 12 hour light/dark cycle and
received food and water at libitum. During the studies, access to water was modified as
outlined in the experimental designs described below. All experimental procedures were
carried out in accordance with the Guidelines on the Care and Use of Laboratory Animals
as published by the Canadian Council on Animal Care (CCAC) and approved by the
Animal Care Committee at The University of Western Ontario. All reagents used in the
experiments were purchased from VWR International, Mississauga, Ontario, Canada.

2.2 Experimental design
2.2.1 Dehydration study
The purpose of the study was to evaluate the effect of dehydration on Stc-1
mRNA, protein and receptor expression in the kidney. Control and experimental rats were
placed into separate cages and weighed prior to each study. Experimental rats were
deprived of water for 12, 24 or 48 hours. Control rats had access to water at all times.
Animals were weighed every 12 hours to monitor the degree of dehydration until
sacrifice. A 15% weight loss was accepted as the maximum permitted weight loss due to
dehydration in accordance with CCAC guidelines.
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2.2.2 Overhydration study
This study was designed to evaluate the effect of overhydration on Stc-1 mRNA
expression in the kidney. Control and experimental rats were placed into separate cages
and weighed. Experimental rats were provided with drinking water containing 20%
sucrose for 48 hours in order to increase water intake. Control rats received regular
drinking water for the same period of time. At the end of a 48 hour experimental period
animals were weighed and sacrificed.

2.2.3 Dehydration study with Via or V2 ADH receptor blockade
This model was developed to study the possible regulation of Stc-1 by ADH
through V ia and V2 receptors. Competitive V ia or V2 receptor antagonists were used.
OPC-21268 was used to block V ia receptors. And OPC-31260 was used for V2 receptor
blockade. Both antagonists were provided by Otsuka Pharmaceutical Co., Ltd., KandaTsukasamachi, Chiyoda-ku, Tokyo, Japan. Both OPC-21268 and OPC-31260 compounds
were resuspended in 5% gum Arabic in water and administered to the rats by oral gavages
at a dose of 40 mg/kg. Rats were weighed every 12 hours to monitor the degree of
dehydration.
The study was conducted as follows:
Group #1: Hydrated control rats which had access to drinking water at all times.
Group #2: Dehydrated control rats which were deprived of water for 48 hours.
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Group #3: Dehydrated rats which were deprived of water for 48 hours and received OPC21268 compound in the last

1 2

hours of the water deprivation period.

Group #4: Dehydrated rats which were deprived of water for 48 hours and received OPC31260 compound in the last

1 2

hours of the water deprivation period.

2.2.4 DDAVP study
Rats were anesthetized with and Ketamine/Domitor ( 8 mg per 100 g body weight
Ketamine and 0.02 mg per 100 g body weight Domitor, i.p). An incision was made
between the shoulder blades and osmotic minipumps (Alzet, Durect Corporation,
Cupertino, CA, USA) containing DDAVP in PBS (pH 7.4) PBS alone were placed under
the skin of experimental and control rats. Then the skin was sutured. Both solutions were
released at the rate of 10 pl/hour which resulted in the. administration of DDAVP at the
dose of 5 pg/kg/day. The treatment was continued for 48 hours before the animals were
sacrificed.
As a closing remark I would like to acknowledge an extensive help of Jeffrey
Turner with this experiment.

2.3 Tissue preparation
Control and experimental animals from the above studies were anesthetized with a
mixture of Ketamine and Domitor

(8

mg per 100 g body weight Ketamine and 0.02 mg

per 100 g body weight Domitor, i.p). The depth of narcosis was monitored using comeal
and spinal pain reflexes. Blood for serum analysis was obtained by cardiac puncture.
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Urine was obtained from all animals by bladder puncture. Kidneys were removed and
placed on ice. Part of the inner medulla and cortex were macrodissected for total mRNA
isolation. The remaining kidney was used for isolation of subcellular fractions such as
nuclei, mitochondria and membranes (procedure described below).

2.3.1 Perfusion and fixation for histological studies
Some experimental and control rats from the studies described above were
perfusion fixed and the kidneys were paraffin embedded for histological studies.
Perfusion fixation was performed on anesthetized animals by inserting an 18 gauge
needle into left ventricle which was then advanced into the aortic arch and secured with
forceps. Perfusion with cold PBS (pH 7.4) was then initiated at a flow rate of 40 ml/min
using a peristaltic pump. A total of 250 ml PBS was perfused followed by the perfusion
of 400 ml of cold 4% paraformaldehyde dissolved in PBS. Perfusion efficacy was
assessed by liver blanching, the analysis of muscle twitching and general body stiffness.
Fixed kidneys were dissected, paraffin embedded and 5pm sections were cut and
mounted on positive charged, Superfrost slides.

2.3.2 Total RNA isolation for real-time RT-PCR
One milliliter of TRIzol (Invitrogen, Carlsbad, CA, USA) per 100 pg of tissue
was used for total RNA isolation. TRIzol was added immediately after the tissues were
removed and tissues were then homogenized using a motorized pestle homogenizer
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(VWR). Total RNA was isolated according to the manufacturer’s instructions. Isolated
RNA was resuspended in DEPC-treated water (Invitrogen, Carlsbad, CA, USA),
aliquoted and stored at -80°C.
RNA was quantified at 260 nm using a NanoDrop 2000c spectrophotometer
(Thermo Scientific, Waltham, MA, USA) and 260/280 absorbance ratio was obtained to
assess its purity. An absorbance ratio of 1.5-2.0 was considered acceptable for PCR
reactions. Integrity of the isolated RNA was assessed on a 1% denaturing agarose gel. An
example of RNA quality is demonstrated in Figure 4.
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Figure 4. Representative example of extracted total RNA. RNA
quality is demonstrated by the integrity of the 18S and 28S ribosomal
RNA bands which are visualized in the RNA sample with
ethidium bromide.
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2.4 Real-time RT-PCR for Stc-1 gene expression
Stc-1 mRNA levels were assessed by quantitative real-time RT-PCR. Relative
quantification by the comparative cycle threshold method (delta-delta-C-r) was performed
using GAPDH as a reference gene.

Stable GAPDH mRNA levels were established

between the control and experimental groups as a necessary pre-condition to its use as a
reference gene.
TaqMan Stc-1 and GAPDH gene expression assays with TaqMan one-step RTPCR master mix were employed according to the manufacturer’s directions (Applied
Biosystems, Foster City, CA, USA). Twenty-five ng of total RNA was used for each
reaction. Reactions were prepared in quadruplicate on a clear 384 well plate and run on an
ABI Prism 7900 HT sequence detector which was set for the following program:
Step#l: 30 minutes at 48°C- reverse transcription
Step#2: 10 minutes at 95°C- activation of AmpliTaq Gold® DNA Polymerase
Step#3: 40 cycles of amplification reaction consisting of 15 seconds at 95°C (Denature)
with the subsequent 1 minute at 60°C (Anneal/Extend).
Data analysis was performed using Sequence Detection Software 2.0 (Applied
Biosystems, Foster City, CA, USA). Quality of reactions was assessed using standard
curve analysis. Efficiencies no less than 90% were deemed acceptable.
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2.5 Receptor binding and radioimmunoassays
Receptor binding assays were carried out on each subcellular fraction using a
fusion protein of STC-1 and human placental alkaline phosphatase (STC-AP) as
previously described. (McCudden et al. 2002), whereas human placental alkaline
phosphatase (AP) was used to estimate the nonspecific binding.
Triplicate 100 pg aliquots of total protein from each subcellular fraction were
incubated in 1.5ml eppendorf tubes with 500 mU/ml of STC-AP or AP for 1.5 hours at
room temperature in Hanks Balanced Salt Solution with bovine serum albumin (HBHA.
Unbound STC-AP or AP was removed by 3 washes in HBHA. The HBHA buffer was
then replaced with 200pl of lysis buffer (1% Triton X-100 in 10 mM Tris, pH 8.0), pellets
were resuspended and samples incubated at 65 °C for 45 min to destroy any endogenous
alkaline phosphatase activity. Detection was performed by adding p-Nitrophenyl
phosphate as a substrate (Sigma-Aldrich Inc., St. Louis, MO, USA) in ethanolamine
buffer (6.3 mg/ml p-Nitrophenyl phosphate in 1 M ethanolamine, 0.5 M MgCh, 0.5
mg/ml bovine serum albumin). The reaction was allowed to proceed for 40 min, after
which time the reaction was stopped by the addition of 100 pi of 3M NaOH. The
reactions were quantified spectrophotometrically at 405 nm and estimates of specific
binding were determined as previously described (McCudden et al. 2002). The
nonspecific binding of AP was taken into account and the final results were expressed as
amount of specifically bound STC-AP (pmoles) per mg of protein.
Subcellular fractions from control and dehydrated cortical kidney samples (400
pg/each) were assayed in triplicate by radioimmunoassay for STC-1 protein content. The

47

radioimmunoassay has been characterized for specificity, does not significantly crossreact
with other peptide hormones, and has a detection limit of 0.2 ng/ml.

(De Niu et al.

1998).

2.6 Histological studies
2.6.1 In situ ligand binding studies
The STC-1 fusion protein (STC-AP) was also used for histological localization of
STC-1 receptor as previously described. (McCudden et al. 2002) Paraffin embedded
kidney sections were deparaffinized in xylene, rehydrated in a series of alcohols and then
equilibrated in HBHA buffer. Slides were then incubated with STC-AP or AP alone (for
non specific staining) for 1.5 hours in HBHA buffer at room temperature. After
incubation, the slides were washed in HBHA containing 0.2% Tween for 5 min and then
fixed for 30 sec in 20 mM HEPES (4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid)
buffer containing 60% acetone and 3% formaldehyde. Slides were then rinsed in Higgins
detection buffer (0.1M Tris-Cl, 0.1M NaCl, 5mM MgCl, pH 9.0) and incubated at 65°C
for 40 min to destroy any endogenous alkaline phosphatase activity. Finally, detection
was carried out using 0.34% 4-Nitro blue tetrazolium chloride (NBT) and 0.34% 5Bromo-4-chloro-3-indoly 1-phosphate (BCIP) as substrates (Roche Diagnostics GmbH,
Indianapolis, IN, USA) added to the detection buffer. The reaction was stopped after 30
minutes.
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2.6.2 Immunocytochemistry
Slides containing kidney sections were deparaffinized in xylene and rehydrated in
a series of alcohols. Endogenous peroxidase activity was eliminated by incubation in
0.3% H2 O2 for 30 min. A blocking step was then performed with 3% bovine serum
albumin and 3% normal goat serum in PBS (pH 7.4) for 1 hour at room temperature after
which the slides were incubated with a polyclonal serum to recombinant human
stanniocalcin-1 (dilution 1:2000) at 4°C overnight (De Niu et al. 2000). Visualization of
antibody binding was performed with the Vectastain ABC kit (Vector Laboratories, Inc.,
Burlingame, CA, USA) according to the manufacture’s instructions.

2.8 Osmolality measurements
Blood collected from rats by cardiac puncture was allowed to clot over night at
4°C. Samples were then centrifuged at 1000 x g and the clear supernatant (serum) was
obtained for analysis. Urine was also centrifuged at 1000 x g and the clear supernatant
was used for osmolality measurements. Osmolalities were measured on a VAPRO 5520
vapor pressure osmometer (Wescor Inc.) using a sample volume of 10 ul.

2.9 Statistical analysis

All data are expressed as the mean ± SEM. Comparisons of two means were
performed with a two-tailed, paired t-test. One-way analysis of variance (ANOVA) was
employed for comparison of multiple means. A Bonferroni’s post-hoc test was used for
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comparison of multiple means when necessary. A p value of < 0.05 was considered
statistically significant. All statistical analyses were performed using GraphPad Prism 4
software (GraphPad software Inc.).
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3 Results
3.1 Dehydration study
3.1.1 Body weight, serum and urine parameters
The body weights of dehydrated animals and their hydrated controls were
monitored in order to assess the degree of dehydration (Table 1). As expected, body
weight was decreased by dehydration 5.3 % after 12 hours, 9.6 % after 24 hours and
11.3% after 48 hours. This progressive decrease in body weight was attributed to a loss of
total body water. In contrast, hydrated animals gained 0.7, 3.5 and 2.8% of body weight
during 12, 24 and 48 hours of the experimental period, respectively.
End point urine and serum osmolalities were also measured for a more accurate
estimation of dehydration severity. The urine osmolality data is presented in Figure 5.
Urine osmolality increased 1.6 fold after 12 hours of dehydration, 1.5 fold after 24 hours
and 1.8 fold after 48 hours, indicating activation of the urine concentrating mechanisms in
order to conserve water.
Table 1: Mean body weight of male Wistar rats before and after the course of
dehydration.
Treatment Group
12 hr hydrated (N=6)
12 hr dehydrated (N=6)
24 hr hydrated (N=6)
24 hr dehydrated (N=6)
48 hr hydrated (N=8)
48 hr dehydrated (N=8)

Before (g)
305.2 ±6.4
307.8 ±3.7
246.2±3.8
246.2±5.6
325.0± 22.4
314.1 ±20.8

After (g)
307.3±6.8
291.7±9.2**
255.2±4.3***
224.7±5.3**
333.4± 20.8**
284.5± 22.9***

Change (%)
0.7 ±0.7
-5.3± 0.8
3.5 ±0.5
-9.6±0.6
2 .8 ± 0 . 8
- 1 1 .3± 1 . 6

Values are shown as means ± SEM. **p<0.01, ***p<0.001, paired t-test vs. starting weight, N-sample size.
% change indicates the difference between initial and final body weights.
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Figure 5. Urine osmolality in rats after dehydration. Urine osmolality was increased
following 12 (A), 24 (B) and 48 (C) hours of dehydration as compared to the respective
hydrated control animals (* p<0.05, **p<0.01, *** p<0.001, paired t-test; N-sample size).
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Figure 6. Serum osmolality in rats after dehydration. There was no change in blood
plasma osmolality following 12 (A) or 24 (B) hours of dehydration. Increased serum
osmolality was demonstrated following 48 (C) hours of dehydration when compared to
hydrated control animals (**p<0.01, paired t-test; N-sample size).
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Serum osmolalities are shown in Figure 6. Serum osmolality was not significantly
different from hydrated control animals after 12 or 24 hours of dehydration. However,
increase in serum osmolalities were demonstrated after a 48 hour dehydration course.
The similarities between serum osmolalities in 12 and 24 hour rats indicated they
had a similar level of dehydration, despite their different lengths of water deprivation.
This may be explained by their circadian drinking habits. The entire 12 hour dehydration
took place during the night when rats are most actively drinking, whereas the 24 hour
dehydration included these same 12 nighttime hours and 12 hours of daytime inactivity,
when little drinking takes place (Johnson and Johnson. 1990).

3.1.2 Stc-1 mRNA levels
Stc-1 mRNA levels were assessed after water deprivation in the kidney cortex and
inner medulla by real-time RT PCR. In the cortex, Stc-1 mRNA levels were ~ 4 fold
higher in dehydrated rats as compared to hydrated controls following 12 hours of water
deprivation. The same magnitude of Stc-1 gene upregulation was observed after 24 hours
of dehydration (~ 3.7 fold increase). A 48 hour dehydration caused an even greater
increase in Stc-1 mRNA levels that reached a ~ 6.3 fold maximum as compared to
hydrated controls. The similar degrees in gene upregulation after 12 hour and 24 hours
can be attributed to the circadian effects on dehydration as described above. Recall as
well that, the assessments of weight loss and urine and serum osmolalities also showed
that these animals were dehydrated to the same degree after 12 and 24 hours (Figure 5
&6, Table 1).
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Figure 7. Relative Stc-1 mRNA levels in rat kidney cortex following 12, 24 and 48
hours of dehydration. Rats were deprived of water for 12, 24 or 48 hours. Relative Stc1 mRNA levels were increased in all dehydrated groups as compared to hydrated control
animals ( * p<0.05, **p<0.01 *** p<0.001, paired t-test; N-sample size).
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Figure 8. Relative Stc-1 mRNA levels in rat inner medullary kidney following 24 and
48 hours of dehydration. Rats were deprived of water for 24 or 48 hours. Relative Stc-1
mRNA levels were significantly increased following a 48 hour dehydration period but not
a 24 hr period when compared to hydrated control animals (* p<0.05, paired t-test; Nsample size).
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Figure 7 depicts the changes in Stc-1 mRNA levels in the cortex after 12, 24 and 48 hours
of dehydration.
As shown in Figure 8, upregulation in Stc-1 mRNA levels following dehydration
was also observed in the inner medulla. However, unlike the response seen in the cortex,
the increase in medullary Stc-1 mRNA levels was much smaller in magnitude and
delayed in time. Here, mRNA levels were increased only after a 48 hour dehydration (~
3.8 fold). The 24 hour dehydration did not produce a significant change in medullary
mRNA levels.
Results indicated that STC-1 protein levels were also increased during
dehydration (Figure 10). STC-1 protein was measured using STC-1 radioimmunoassay to
look at various subcellular fractions including mitochondria, nuclei and plasma
membranes following a 24 hour water deprivation. The results showed an increase in
STC-1 protein in all subcellular fractions, with the greatest increase in the mitochondrial
fraction. This finding allowed us to conclude that the upregulation in Stc-1 mRNA levels
indeed resulted in an increase in STC-1 production.

3.1.3 Kidney receptor levels and subcellular distribution during dehydration
Receptor binding assays were performed on various kidney subcellular fractions
to assess changes in STC-1 targeting during dehydration. Figure 9 shows the amount of
STC-1 binding on plasma membranes, mitochondria and nuclei of hydrated animals
(control) and animals dehydrated for 48 hours. In both the dehydrated and hydrated state,
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Figure 9. STC-1 receptor levels on kidney plasma membrane, mitochondria and
nuclear subcellular fractions following a 48 hour dehydration period. A significant
increase in receptor levels was seen only in the mitochondrial fraction of dehydrated
animals, whereas those in the other fractions remained unchanged following dehydration
(* p<0.05, paired t-test; N-sample size).
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Figure 10. STC-1 levels in kidney plasma membrane, mitochondria and nuclear
subcellular fractoins following a 48 hour dehydration period. A significant increase
in STC-1 levels was seen in all subcellular fractions of dehydrated animals with the
greatest increase in mitochondrial fraction (* p<0.05, paired t-test; N-sample size).
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the highest degree of binding was observed in the mitochondria followed by the plasma
membranes. The lowest binding was present in the nuclear fraction under both conditions.
After 48 hour dehydration the number of STC-1 binding sites in the nuclear and
membrane fraction was unchanged. However, a small but statistically significant increase
in binding was evident in the mitochondria of dehydrated animals, indicative of the
increased targeting to the mitochondria during dehydration. This is of great interest
because the mitochondria are the primary focus of STC-1 targeting and function in kidney
tissue.

3.1.4 Histological localization of STC-1 receptor and protein during dehydration
Figure 11 shows in situ STC-1 receptor binding sites in hydrated animals and in
those subject to a 48 hour dehydration. In both hydrated and dehydrated rats, the highest
level of STC-1 binding was observed in the collecting duct and the lowest levels were in
the proximal convoluted tubules (SI segment) and glomeruli. Similar binding
characteristics were also seen in the kidneys of rats dehydrated for 12 or 24 hours (data
not shown). In summary, there were no apparent changes in STC-1 receptor density or
distribution along the nephron in response to dehydration, which agrees with the
previously described receptor binding data.
The immunostaining of kidney sections from rats dehydrated for 48 hours
revealed similar distribution patterns of STC-1 protein as seen in control animals (Figure
12). The highest amount of STC-1 was present in the collecting duct and the lowest levels
were once more seen in the proximal convoluted tubules and glomeruli. Similar results
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Figure 11. In situ ligand binding for STC-1 receptor in the kidney cortex and inner
medulla of rats following 48 hours of dehydration. There was no observable difference
in STC-1 receptor localization in nephron segments of hydrated and dehydrated rats.
Scale bar 50pm.
(Abbreviations: CCD-cortical collecting duct; D CT- distal convoluted tubule; Glom glom erulus; IM CD- inner medullary collecting duct; PCT-proximal convoluted tubule).
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Figure 12. Immunostaining for STC-1 protein in the rat kidney cortex and inner
medulla following 48 hours of dehydration. There was no observable difference in
STC-1 protein localization in nephron segments of hydrated and dehydrated rats. Scale
bar 50pm.
(Abbreviations: CCD-cortical collecting duct; D C T- distal convoluted tubule; G lom glomerulus; IM CD- inner medullary collecting duct; PCT-proximal convoluted tubule).
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were seen in the kidneys of rats dehydrated for 12 or 24 hours (data not shown).

This

data also agrees with the previously described receptor binding data and further supports
the notion that STC-1 targeting remains unchanged during dehydration.

3.2 Dehydration study with Via or V2 receptor blockade
Once it was shown that Stc-1 mRNA levels were upregulated during dehydration,
a study was designed to evaluate the contribution of vasopressin to the induction of Stc-1
mRNA levels, given it is a major contributor to water conservation. Specific V ia and V2
receptor blockers were used to determine the effects of vasopressin on Stc-1 mRNA
levels during dehydration. In this study, all groups except the hydrated controls were
deprived of water for 48 hours. The receptor blockers or vehicle alone were then
administered in the last 12 hours of the experiment.

3.2.1 Body weight, serum and urine osmolalities during dehydration + vasopressin
blockade
Rats dehydrated for 48 hours and administered vehicle alone lost 13.6 % of their
starting body weight, while hydrated rats gained an average of 6.9%. Similarly, a
significant weight loss was also observed in dehydrated rats that received either the V2 or
V ia receptor blocker in the last 12 hours (Table 2). There was no significant difference in
the degree of weight loss between rats which were treated with V ia or V2 receptor
blockers in comparison to the dehydrated rats that received vehicle only. Again this
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decrease in the body weight can be attributed to loss of total body water. Therefore, the
results indicate that all dehydrated rats, regardless of the receptor blocker administered,
had similar degrees of total body water contraction.
The assessment of urine osmolality revealed that 48 hours dehydration resulted in
a 2.2 fold increase over controls (Figure 13), which is consistent with previous studies.
The administration of V ia or V2 receptor blockers in the last 12 hours of dehydration did
not cause a statistically significant drop in urine osmolality as expected, although a trend
towards lower urine osmolalities was observed.
Serum osmolalities in all groups of dehydrated rats were higher than in hydrated
rats as expected (Figure 14). There was also a trend toward a greater increase in serum
osmolality in dehydrated rats that received either the V ia or V2 receptor blocker as
compared to dehydrated, untreated animals. However, this trend was not statistically
significant (Figure 14)

Table 2: Mean body weight of male Wistar rats before and after 48 hours of
dehydration.
Treatment Group
Hydrated, Vehicle (N=8)
Dehydrated, Vehicle (N=8)
Dehydrated, Via (N=8)
Dehydrated, V2 (N=8)

Before (g)
266.6± 13.0
259.3± 15.5
264.0 ±12.9
261.6 ±12.4

After (g)
286.0±12.5**
228.1± 13.3***
233.3± 11.9***
227.9± 10.8***

Change (%)
6.904±0.8
-13.59±0.5
-13.26± 0.6
-14.83± 0.5

Values are shown as means ± SEM. **p<0.01, ***p<0.001, paired t-test vs. starting weight, N-sample size.
% change indicates the difference between initial and final body weights.
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3.2.2 Stc-1 mRNA levels
Figure 15 shows Stc-1 mRNA levels in the kidney cortex of hydrated rats, dehydrated
control rats and dehydrated rats that received either the V ia or V2 receptor blocker. In the
cortex, Stc-1 mRNA levels were increased after 48 hour of dehydration. An increase in
Stc-1 mRNA levels was also observed in dehydrated rats that received either receptor
blocker. However, Stc-1 mRNA levels in the group of rats given the V2 receptor blocker
were significantly lower than in dehydrated controls. This result suggests that V2 receptor
blockade, during the last 12 hours of dehydration, attenuated the upregulation of Stc-1
mRNA levels following dehydration. More importantly this signifies the involvement of
vasopressin as a regulator of Stc-1 gene expression through the V2 receptor during
dehydration. In contrast, Stc-1 mRNA levels in rats administrated the V ia receptor
blocker were not significantly different than the dehydrated controls, thereby ruling out
the V ia receptor in cortical gene upregulation.
In the inner medulla (Figure 16), Stc-1 mRNA levels were upregulated in
dehydrated animals that received vehicle alone compared to hydrated controls. In this
case, however, the administration of V ia or V2 receptor blockers did not attenuate the
rise in Stc-1 mRNA levels in response to dehydration.

3.3 Stc-1 mRNA upregulation by DDAVP
To confirm that vasopressin does indeed upregulate renal levels of Stc-1 mRNA, a
study was carried out whereby DDAVP, a potent V2 receptor agonist, was administered
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Figure 13. Urine osmolalities in rats following a 48 hour dehydration period with or
without vasopressin receptor blockade. Urine osmolality was increased in all
dehydrated groups when compared to hydrated controls. The increase in urine osmolality
in the groups administered either vasopressin receptor blocker (Via or V2 blocker)
appeared smaller than in the vehicle-treated dehydrated rats, but did not reach statistical
significance (groups with different letters are significantly different than one another at
the p<0.05 level; one-way ANOVA followed by Bonferroni's multiple comparison test;
N-sample size).
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Hydrated

Dehydrated

Figure 14. Serum osmolalities in rats following a 48 hour dehydration period with or
without vasopressin receptor blockade. Serum osmolality was increased in all
dehydrated groups compared to hydrated controls. The increase in serum osmolality in
groups administered either vasopressin receptor blocker (Via or V2 blocker) appeared
higher than in vehicle-treated dehydrated rats, but was not statistically significant.
(Groups with different letters are significantly different than one another at the p<0.05
level; one-way ANOVA followed by Bonferroni's multiple comparison test; N-sample
size.)
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Hydrated

Dehydrated

Figure 15. Relative Stc-1 mRNA levels in rat kidney cortex following a 48 hour
dehydration period with and without vasopressin receptor blockade. Stc-1 mRNA
levels were increased in all dehydrated groups. In the group administered the V2 receptor
blocker, Stc-1 mRNA failed to increase to the same extent as in the control dehydrated
rats. The V ia receptor blocker had no effect on the magnitude of induction as compared
to vehicle-treated control animals (Groups with different letters are significantly different
than one another at the p<0.05 level; one-way ANOVA followed by Bonferroni's multiple
comparison test; N-sample size.)
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Figure 16. Relative Stc-1 mRNA levels in rat inner medullary kidney following a 48
hour dehydration period with or without vasopressin receptor blockade. Stc-1
mRNA levels in rats administrated the V ia receptor blocker were not significantly
different than dehydrated controls. Stc-1 mRNA levels in rats administered the V2
receptor blocker were not significantly different than the hydrated or dehydrated controls,
(one-way ANOVA followed by Bonferroni's multiple comparison test; groups with
different letters are significantly different than one another at the p<0.05 level; N-sample
size).
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Inner medulla

Cortex

Figure 17. Relative Stc-1 mRNA levels in rat kidney following a 48 hour DDAVP
infusion. Rats were treated with DDAVP (5 ug/kg/day) or vehicle alone for 48 hours.
Cortical Stc-1 mRNA levels were 3.7 fold higher in DDAVP-treated animals compared to
vehicle-treated controls. In contrast, medullary mRNA levels were 1.7 fold lower in
DDAVP-treated animals

(* p<0.05, *** p<0.001, one-way ANOVA followed by

Bonferroni's multiple comparison test; N-sample size).
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to hydrated rats for 48 hours. Stc-l mRNA levels from the kidney cortex and inner
medulla were measured and compared to control animals which received vehicle only. A
~3.7 fold upregulation in Stc-l mRNA levels was observed in the kidney cortex after
DDAVP treatment (Figure 17). This finding showed that vasopressin, acting through the
V2 receptor was capable of upregulating Stc-l mRNA levels and likely contributed to
gene upregulation during dehydration. Interestingly, a ~1.7 fold decrease in Stc-l mRNA
levels was observed in the inner medulla of DDAVP treated rats (Figure 17). This
suggests that the gene is regulated differently here and implies that some other factor is
responsible for the upregulation of the inner medullary gene during dehydration.

3.4 Overhydration study
Both control and overhydrated rats gained weight during the course of the study.
However, no difference in weight gain was observed between the two groups indicating
that overhydration did not significantly affect extracellular fluid volume (Table 3). Figure
18 shows urine osmolalities of control and overhydrated rats. Urine osmolality declined ~
2 fold as a consequence of overhydration, indicating that overhydration was effective.
Real-time RT PCR showed no difference in cortical or medullary Stc-l mRNA
levels after 48 hours of overhydration when compared to control animals (Figures 19 &
20). In situ ligand binding showed no noticeable changes in the receptor levels or
distribution in overhydrated rats in comparison to hydrated controls. In addition, there
were no changes in the immunostaining patterns for STC-1 protein in the PT, CD, TAL or
DCT of either overhydrated and control animals (results are not shown).

Table 3: Mean body weight of male Wistar rats before and after the course of
overhydration.
Change (%)
After (g)
Before (g)
6.3±0.7
279.5±9.1 ***
262.3 ±10.1
48 hr hydrated (N=8)
6 .1± 1.2
278.5 ±11.4***
261.6 ±11.7
48 hr overhydrated (N=8)
Values are shown as means ± SEM. , ***p<0.001, paired t-test vs. starting weight, N-sample size.
Treatment Group

% change indicates the difference between initial and final body weights.

normally hydrated overhydrated

Figure 18. Urine osmolality following a 48 hour overhydration period. Urine
osmolality decreased after 48 hours of overhydration when compared to hydrated animals
(*p<0.05, paired t-test; N-sample size).
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normally hydrated overhydrated

Figure 19. Relative Stc-1 mRNA levels in rat kidney cortex following 48 hours of
overhydration. Stc-1 mRNA levels were no different in overhydrated and normally
hydrated rats (paired t-test; N-sample size).

Inner medulla
2.0n

normally hydrated overhydrated

Figure 20. Relative Stc-1 mRNA levels in rat kidney inner medulla following 48
hours of overhydration. Stc-1 mRNA levels were no different in overhydrated and
normally hydrated rats (paired t-test; N-sample size).
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4 Discussion
4.1 Summary of results
The first novel finding of the present study was the significant upregulation in Stc1 mRNA levels in kidney cortex and inner medulla in response to dehydration. This
suggested that STC-1 function in the kidney might be connected either to water
conservation mechanisms or nephron cellular adjustment to hyperosmolar stress. It also
opened the door to studies on specific mechanisms that regulated the gene under these
conditions, in particular, the possible influences of ADH and hyperosmolality. This was
explored in a subsequent project (Turner J.K., et al. 2010). The study also suggested that
the Stc-1 gene was regulated differentially in cortex and inner medulla, a notion which
was subsequently confirmed (Turner J.K., et al. 2010). Stc-1 mRNA levels were also
studied during overhydration, where water balance was altered in the opposite direction.
However, in this case no changes in Stc-1 mRNA levels were observed in cortex or inner
medulla. This may have been due to the Stc-1 gene response to osmolar stress being
unidirectional. Alternatively, baseline levels of Stc-1 mRNA may already have been
sufficiently low that downward changes could not be reliably measured.
The other focus of the study was STC-1 targeting following alterations in water
balance. STC-1 targeting along the nephron segments and to different subcellular
organelles were both addressed. The results showed that STC-1 was targeted to the same
nephron segments during dehydration, overhydration and in normally hydrated rats. Also,
no major shifts in STC-1 receptor levels were seen at the subcellular level, where the
ligand is known to preferentially target the mitochondria fraction (McCudden et al. 2002).
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However, a small increase in STC-1 targeting to mitochondria was observed during
dehydration.
The second important finding described in the thesis is that Stc-1 mRNA levels
in kidney cortex proved to be regulated by ADH acting through the V2 receptor. This was
revealed in two different experimental models: receptor blockade and agonist studies.
Finally, the data suggested that the cortical and inner medullary genes were
differentially regulated.

4.2 Dehydration as a newly identified inducer of the renal Stc-1 gene
The present study has shown that dehydration causes an increase in Stc-1 mRNA
levels in both cortex and inner medulla. In the cortex, 12, 24 and 48 hours of dehydration
resulted in 4, 3.7 and 6.3 fold increases in Stc-1 mRNA levels respectively. It was
concluded that Stc-1 mRNA levels increased along with the severity of dehydration. In
accordance with this conclusion, a follow-up study has revealed that Stc-1 mRNA levels
are increased even further (8 fold) in response to 72 hours of water deprivation (Turner
J.K., et al. 2010).
The 12 and 24 hour water deprivation resulted in similar degrees of gene
induction due to there being similar degree dehydration, as confirmed by measurements
of serum osmolality. Circadian rhythm is most likely responsible for the similar degrees
of dehydration, because the 12 hour dehydration was conducted entirely during the night
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when rats drink the most, whereas the 24 hour dehydration encompassed both the night
and the daytime when rats drink little (Johnson and Johnson. 1990).
In general, there is limited information available on Stc-1 gene regulation in the
mammalian kidney. It has been shown that a high Ca

diet downregulates of Stc-1

mRNA levels (Deol et al. 2001). One other study has shown that calcitriol, the active
form of vitamin D3, increases renal Stc-1 mRNA levels (Honda et al. 1999). Although
both of these studies linked STC-1 to its possible involvement in Ca

homeostasis,

functional studies have failed to show any effects of STC-1 injections on serum Ca
levels (Wagner et al. 1997). Moreover, as Ca

homeostasis is not altered during

dehydration (Bennett and Gardiner. 1987a; Zucker et al. 1982; Merrill et al. 1986), the
present findings highlight the notion that renal STC-1 must have functions other than
those related to calcium. Since dehydration is a complex condition that triggers multiple
adaptive mechanisms, the factors responsible for STC-1 upregulation under these
circumstances became the focus of the project.
As mentioned earlier, high osmolality is one component of dehydration thought to
be responsible for the induction of Stc-1 mRNA levels. The evidence in support of high
osmolality comes from the studies on MDCK cells, a mammalian kidney cell line. The
level of Stc-1 mRNA and ligand secretion are both upregulated in MDCK cells upon
incubation in a media made hypertonic with non-permeant ions such as NaCl and
raffinose. As both solutes caused an increase in Stc-1 mRNA levels and secretion, this
indicated that the hyperosmolar effect was not Na+ specific (Sazonova et al. 2008b;
Sheikh-Hamad et al. 2000).
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In vivo progressive dehydration increases interstitial fluid osmolality in the inner
medulla. In contrast, osmolalities in the kidney cortex rise in tandem with those of serum.
However, because the adaptive mechanisms are directed to limiting the increase in serum
osmolality during dehydration rise in cortical interstitial fluid osmolality is modest as
compared to inner medulla (Seldin and Giebisch. 1992; Selen and Persson. 1983c).
In marked contrast to the osmolality changes outlined above, Stc-1 mRNA levels
were upregulated to a much greater extent in the cortex than the medulla. Indeed, the
inverse would have been anticipated where osmolality is the primary factor affecting gene
expression. Furthermore, Stc-1 mRNA levels were increased by 24 hours of dehydration
without significant changes in serum osmolality. Therefore, it must be concluded that
factors other than osmolality were driving the increase in cortical gene activity.
Also surprising, was how large the difference was in gene induction between
cortex and inner medulla 6.3 vs. 3.8 fold (following 48 hours of dehydration). In part, the
difference might be explained by the fact that baseline Stc-1 mRNA levels are higher in
inner medulla to begin with (3 fold higher), such that the requisite rise in Stc-1 mRNA
levels was achieved that much faster. Alternatively, it is possible that Stc-1 mRNA levels
are differentially regulated in these two regions and evidence of the latter emerged in the
studies on ADH and specific receptor agonists.

4.3 ADH as a possible regulator of Stc-1 mRNA levels in the kidney cortex
In the attempt to identify factors responsible for Stc-1 gene induction during
dehydration, ADH was viewed as a possible candidate. ADH plays a major role during
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dehydration by regulating most of the mechanisms involved in the processes of water
conservation, controlled natriuresis and cellular adjustments to hyperosmotic stress
(Seldin and Giebisch. 1992), as described in the Introduction. Therefore, ADH was
potentially responsible for upregulating Stc-1 mRNA levels during dehydration through
one or more receptor subtypes.
Specific drugs that competitively block V ia or V2 receptors were first employed
to assess the possible involvement of ADH. Rats were dehydrated for 48 hours and Via
or V2 receptors were blocked by the administration of antagonists during the last 12
hours. The results showed that V2 receptor blockade significantly attenuated the
upregulation of Stc-1 mRNA levels in kidney cortex following dehydration, suggesting
that the cortical gene was regulated through the V2 receptor. V ia receptor blockade failed
to suppress the gene, suggesting that it was not involved.
In the inner medulla, the results were less clear. Here, it was not possible to
confirm the involvement of either the V ia or V2 receptor subtype. Stc-1 mRNA levels
were no different in the dehydrated rats administered either the V ia or V2 blockers,
although those that received the V2 blocker were no longer significantly different than
hydrated controls. Therefore, while the data does not necessarily rule out the role for the
V2 receptor in inner medulla, the case was not as strong as in the cortex.
In view of the findings obtained with these antagonists, it was also important to
address the issue of the effectiveness in the blockade. The efficiency of receptor blockade
was monitored by changes in body weight, as well as urine and serum osmolalities. The
question as to whether the receptors were effectively blocked has been raised because
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neither antagonist had any significant differences in the body weights, serum or urine
osmolalities. It was expected that urine osmolalities would drop and serum osmolalities
would rise in response to V2 receptor blockade. Trends were evident in rats treated with
OPC 31260. However, statistically significant changes were not achieved. Taking into
account the fact that V2 blockade suppressed the increase in cortical Stc-1 mRNA levels,
it must be concluded that V2 receptor blockade was indeed effective. However, the minor
changes in urine and serum osmolality in the face of V2 blockade may be explained by
the existence of parallel mechanisms that operate independently of the V2 receptor, and
continued to promote urine concentration. Others have shown that, dehydration continues
to promote translocation of AQP2 to the apical membrane of the CD cells and water
reabsorption even in the presence of V2 blockade (Marples et al. 1998). Secretin has been
identified as being responsible for the AQP2 translocation, essentially bypassing the V2
receptor (Chu et al. 2007).
It is likely because of these parallel pathways that it was not possible to
completely suppress the water conservation mechanism. Also, it should be noted that V2
receptor blockade caused only a small decrease in cortical Stc-1 mRNA levels in
comparison to the rise brought about by dehydration. Because of these limitations further
studies were carried out using a specific V2 receptor agonist.
The specific V2 receptor agonist, DDAVP, was employed to further evaluate the
involvement of V2 receptors. The results showed that following DDAVP infusion, Stc-1
mRNA levels were increased 3.7 fold in cortex, but decreased 1.7 fold in inner medulla.
This confirmed that the cortical gene was indeed being regulated through the V2 receptor.
The results also highlighted the fact that the gene was differentially regulated in the
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cortex and medulla. Importantly, the fact that inner medullary gene activity was increased
during dehydration but was reduced by V2 activation implies that other factors must
overcome the V2 -dependent downregulation during water deprivation. These factors
have yet to be identified.
Both the V ia and V2 receptors, through which ADH acts, are expressed in CD
cells where the Stc-1 gene is also expressed, and normally these receptors are more
concentrated in the inner medulla. However, the literature shows that the number of
functional ADH receptors is increased considerably in cortical CD cells during
dehydration, in comparison to the inner medulla where they remain unchanged. Such a
shift in receptor expression levels implies an increase in ADH targeting to the cortical
segment during dehydration (Fadool and Aggarwal. 1990). Therefore Stc-1 mRNA
upregulation during dehydration could follow the shifting pattern in ADH targeting.
The question also remains as to whether the V2 receptor dependent mechanism is
the only one that upregulates Stc-1 mRNA levels in the cortex? In answer to this,
subsequent studies have been able to show that high osmolality produced by either
mannitol or sodium chloride also upregulated the cortical gene. However, the fold
changes brought in by osmolality alone were not so high as those due to dehydration
(Turner J.K., et al. 2010). Therefore, osmolality may be an important factor in regulating
the gene in addition to ADH. Also, further studies with specific V ia receptor agonist,
should be considered to clarify a role for this receptor subtype in Stc-1 gene regulation.
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4.4 STC-1 targeting during dehydration
In situ ligand binding and immunocytochemistry were performed on kidney
sections of control and dehydrated animals to assess STC-1 receptor and protein
distribution patterns along the nephron. The results showed that there were no changes in
either receptor or protein localization patterns, indicative that STC-1 was targeted to the
same nephron segments during dehydration as in the normal, hydrated state (namely PCT,
cortical and medullary TAL, cortical and medullary CD).
Previous studies have shown that in the normally hydrated state, STC-1
production is confined to the CD system, as STC-1 mRNA is present exclusively in this
segment. From CD cells, STC-1 is targeted to upstream nephron segments (PT and TAL)
and sequestered there within the cells (Haddad et al. 1996a; Wong et al. 1998; McCudden
et al. 2002). Whether these same paracrine targeting pathways are preserved in their
entirety during dehydration remains to be established. The receptor and protein
localization patterns would seem to suggest that this is the case. However, in situ
hybridization is also needed to address this question more fully. If STC-1 gene activity
also remains confined the CD system, this would suggest that the same paracrine
targeting pathways are operative along the nephron irrespective of hydration status, but
that their amplitude is increased during dehydration.
STC-1 receptor localization was also studied at the subcellular level to assess
ligand targeting to different organelles. In both hydrated and dehydrated rats the receptors
appeared to be concentrated on the same organelles. The highest number of binding sites
was observed on the mitochondria, followed by the membrane fraction and the cell
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nuclei. A significant increase in mitochondrial binding was seen in dehydrated rats,
however, suggestive of an increase in mitochondrial targeting. This notion was supported
by there being a significant increase in STC-1 protein levels within the mitochondrial
fraction.
4.5 Proposed functional effects of STC-1 during dehydration
STC-1 targeting to the mitochondria results in respiratory uncoupling (Ellard et
al. 2007) which has recently been shown to decrease reactive oxygen species (ROS) in
macrophages (Wang et al. 2009b). As such, ROS reduction could be one role of renal
STC-1 during dehydration. Collectively, ROS comprises superoxide (O2 " ), hydrogen
peroxide (H2 O2 ) and the hydroxyl radical (.OH) (Garvin and Ortiz. 2003). As ROS plays
multiple roles in the kidney, any changes in its levels by STC-1 could have numerous
consequences. One of them would be a reduction in ROS-induced apoptosis (Circu and
Aw. 2010). It is known that ROS production is increased during oxidative stress (Circu
and Aw. 2010). The high extracellular fluid osmolalities present during dehydration have
been shown to induce oxidative stress and increase ROS production (Zhou et al. 2005;
Zhou et al. 2006; Hizoh and Haller. 2002). Subsequently, ROS damages the cells and
initiates apoptotic pathways (Circu and Aw. 2010). Renal STC-1 upregulation might
sufficiently attenuate the increase in ROS and thus act as a prosurvival factor. Notably,
the cytoprotective actions of STC-1 have also been demonstrated in other tissues such as
cardiomyocytes and neurons (Zhang et al. 2000; Westberg et al. 2007b; Westberg et al.
2007a).
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In kidney, however, the effects of ROS are even broader. ROS are now being
commonly viewed as signaling molecules, and have been shown to increase Na+
reabsorption in the TAL (Garvin and Ortiz. 2003). As such, by reducing ROS, STC-1
could conceivably decrease Na+ reabsorption during dehydration. Natriuresis is one of
many compensatory mechanisms that are operating during dehydration to accommodate
the fall in extracellular fluid volume (Merrill et al. 1986). Therefore, it is possible that
STC-1 upregulation is the component of this adaptive mechanism that prevents sodium
overloading during negative water balance.
In addition, ROS, more specifically O2 " , directly influences NO levels. Whereas
NO production is directly dependent on NOS activity, O2 ’ regulates its metabolism. O2
reacts with NO at a very high rate to produce peroxynitrite (ONOO ) which lacks the
physiological effects of NO. Hence, the balance of NO levels depends on both 0 2' and
NOS (Evans and Fitzgerald. 2005b). Because STC-1 is capable of regulating ROS levels
it can likely also modulate NO levels through O2 * .
During dehydration, NO is known to have an important role in promoting both
natriuresis and water reabsorption (Ortiz and Garvin. 2002; Murase et al. 2003; Morishita
et al. 2005). At present, it is known that NOS is upregulated during dehydration which
results in more NO production (Shin et al. 1999). The upregulation of STC-1 during
dehydration could possibly reduce 02* , slow NO catabolism and in this way contribute to
higher steady-state levels of NO. Interestingly, ADH has been shown to induce NOS
during dehydration (Martin et al. 2002) and the present project has identified ADH as a
newly defined regulator of STC-1. Therefore, it can be hypothesized that in addition to its
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regulatory effects on NOS, ADH may upregulate STC-1 as an additional means of NO
control.
The other consequence of respiratory uncoupling involves stimulation of Ca
uniport activity and mitochondrial Ca2+ uptake (Ellard et al. 2007). One study done on
macrophages has demonstrated that STC-1 upregulates UCP-2 (Wang et al. 2009b) which
is required for uniport activation (Trenker et al. 2007). The accumulation of Ca2+ within
mitochondria would tend to lower cytosolic Ca2+ concentrations. Since high cytosolic
Ca2+ is toxic to cells, this effect could also be cytoprotective in nature (Zhang et al. 2000).
In summary, the functional effects of STC-1 during dehydration are possibly
connected to the uncoupling of oxidative phosphorylation, which result in ROS reduction,
an increase in cellular NO and Ca2+ accumulation within the mitochondria. As in the case
of other cell types, the above changes can also be cytoprotective to nephron cells. In
addition to this, through ROS and NO, STC-1 may be regulating major kidney functions
that are altered during dehydration: namely, sodium and water reabsorption. As such,
renal STC-1 could have a role in regulating both the composition and volume of the
extracellular fluid. Finally, as STC-1 targeting appears to be unchanged, though
increased, during dehydration, the ligand could prove to have a similar role in the normal
hydrated state as it does during dehydration.
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